4
Changes in Ownership
Denali Therapeutics Inc. Filed Acc 0001209191-21-016857
Chief Medical Officer sold 7,092 shares at an average $66.38 ($470,741)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ho Carole Chief Medical Officer | 2021-03-01 | Sale | −1,327 | $64.54 | $85,646 | 170,906 | I |
| Ho Carole Chief Medical Officer | 2021-03-01 | Sale | −2,871 | $65.74 | $188,725 | 168,035 | I |
| Ho Carole Chief Medical Officer | 2021-03-01 | Sale | −1,173 | $67.07 | $78,670 | 166,862 | I |
| Ho Carole Chief Medical Officer | 2021-03-01 | Sale | −1,320 | $68.01 | $89,772 | 165,542 | I |
| Ho Carole Chief Medical Officer | 2021-03-01 | Sale | −208 | $68.87 | $14,324 | 165,334 | I |
| Ho Carole Chief Medical Officer | 2021-03-01 | Sale | −125 | $70.07 | $8,758 | 165,209 | I |
| Ho Carole Chief Medical Officer | 2021-03-01 | Sale | −68 | $71.27 | $4,846 | 165,141 | I |
| Open-market sales · 7,092 sh · avg $66.38 · $470,741 | |||||||
Loading xslF345X03/doc4.xml…